(Q33542800)

27 July 2017

title

PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial (English)

1 reference

multicenter clinical trial

27 July 2017

main subject

0 references

1 reference

1 reference

3

Charles B Majoie

1 reference

27 July 2017

8

Yvo B Roos

1 reference

27 July 2017

Koen de Gans

1

1 reference

27 July 2017

Rob J de Haan

2

1 reference

27 July 2017

Maria M Koopman

4

1 reference

27 July 2017

Anneke Brand

5

1 reference

27 July 2017

Marcel G Dijkgraaf

6

1 reference

27 July 2017

Marinus Vermeulen

7

1 reference

27 July 2017

PATCH Investigators

9

1 reference

27 July 2017

publication date

18 March 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

page(s)

19

1 reference

Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Recombinant activated factor VII for acute intracerebral hemorrhage.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Ultra-early hemostatic therapy for intracerebral hemorrhage

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Aspirin-associated intracerebral hemorrhage: clinical and radiologic features

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Prognostic factors in patients with intracerebral haematoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851678

Early hemorrhage growth in patients with intracerebral hemorrhage.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-19

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-19

Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-19

Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-19

Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-19

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-10-19

Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20298539

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral anticoagulant treatment: risk factors involved in 500 intracranial hemorrhages

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20298539

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20298539

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-10-19

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference